Beam Therapeutics
BEAM
#4129
Rank
NZ$4.71 B
Marketcap
NZ$46.51
Share price
-4.95%
Change (1 day)
3.86%
Change (1 year)

Market capitalization of Beam Therapeutics (BEAM)

Market cap: NZ$4.71 Billion

As of March 2026 Beam Therapeutics has a market cap of NZ$4.71 Billion. This makes Beam Therapeutics the world's 4129th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Beam Therapeutics from 2020 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$4.71 B-3.74%
2025NZ$4.90 B25.57%
2024NZ$3.90 B11.29%
2023NZ$3.50 B-19.18%
2022NZ$4.34 B-45.39%
2021NZ$7.94 B21.2%
2020NZ$6.55 B

End of Day market cap according to different sources

On Mar 2nd, 2026 the market cap of Beam Therapeutics was reported to be:

NZ$4.98 Billion
by Nasdaq info icon info icon
NZ$4.96 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
ORIC Pharmaceuticals
ORIC
NZ$2.49 B-47.08%๐Ÿ‡บ๐Ÿ‡ธ USA